Skip to content

Observation on the analgesic effect of spinal dorsal root nerve block in patients with spinal curvature after osteotomy and corrective surgery

Observation on the analgesic effect of spinal dorsal root nerve block in patients with spinal curvature after osteotomy and corrective surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123217
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis surgery

Interventions

Trial Group:Dorsal root ganglion blockade with 0.15% ropivacaine (300 ml, 4-10 ml/h)
postoperative patient-controlled intravenous analgesia (hydromorphone 10 mg + ondansetron 16 mg diluted to 100 mL with normal saline, bolus dose 1 ml, lockout interval 10 min, maximum hourly dose 6 ml
Control Group:No dorsal root ganglion blockade

Sponsors

University of Hong Kong–Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 60 years old; 2. ASA grades I to III; 3. All patients were diagnosed with spinal curvature; 4. Patients scheduled for spinal curvature osteotomy and correction surgery, and the osteotomy range was >= 4 segments; 5. The patients had clear consciousness and stable vital signs.

Exclusion criteria

Exclusion criteria: 1. There is a problem with coagulation function; 2. There is an allergy to anesthetic drugs; 3. Patients with severe liver and kidney dysfunction; 4. Patients with infectious diseases; 5. Patients with severe cardiovascular and cerebrovascular diseases; 6. Patients who have long-term abuse of sedative drugs, opioid drugs, and drugs that affect cognitive function; 7. Patients who experienced severe unexpected situations such as massive bleeding during the operation, making the surgery unable to proceed normally; 8. Patients with a history of spinal surgery in the same area; 9. Patients who experienced a significant decrease in somatosensory/motor evoked potentials during the operation or suspected spinal cord/nerve root injury; 10. Patients who cannot cooperate with the researchers due to cognitive impairment, psychological or mental disorders.

Design outcomes

Primary

MeasureTime frame
The dosage of analgesic drugs that needs to be supplemented during the anesthesia recovery period;

Secondary

MeasureTime frame
The pain numerical rating score at rest within 24 hours after surgery;Dynamic pain NRS score;The total consumption of analgesic drugs in the analgesic pump, the total number of presses and the number of analgesic rescue within 72 hours after surgery.;The occurrence rates of nausea, vomiting, skin itching, respiratory depression and urinary retention within 72 hours after the operation;The sleep quality score 3 days after the operation;

Countries

China

Contacts

Public ContactWang Weixuan

University of Hong Kong–Shenzhen Hospital

wangwx@hku-szh.org+86 159 5945 8935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026